2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2023 | 0 | 3.443.137 | 405.101 | 1 | ||
2019 | 0 | 14.839.774 | 776.508 | 1 | ||
2018 | 0 | 5.990.460 | 982.125 | 1 |
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2023-05-01 | Intelligent design of adenovirus vectors (iAds) | iAds | participant | 3.443.137 | 8 |
2019-01-01 | CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease | CardioReGenix | participant | 14.839.774 | 13 |
2018-01-01 | Stem-cell based gene therapy for recombination deficient SCID (RECOMB) | RECOMB | participant | 5.990.460 | 17 |